Abstract
Micro- and nanoscale robots that can effectively convert diverse energy sources into movement and force represent a rapidly emerging and fascinating robotics research area. Recent advances in the design, fabrication, and operation of micro/nanorobots have greatly enhanced their power, function, and versatility. The new capabilities of these tiny untethered machines indicate immense potential for a variety of biomedical applications. This article reviews recent progress and future perspectives of micro/nanorobots in biomedicine, with a special focus on their potential advantages and applications for directed drug delivery, precision surgery, medical diagnosis, and detoxification. Future success of this technology, to be realized through close collaboration between robotics, medical, and nanotechnology experts, should have a major impact on disease diagnosis, treatment, and prevention.
INTRODUCTION
Robotic systems have markedly extended the reach of human beings in sensing, interacting, manipulating, and transforming the world around us (1). In particular, the confluence of diverse technologies has enabled a revolution in medical applications of robotic technologies toward improving health care. Whereas industrial robots were developed primarily to automate routine and dangerous macroscale manufacturing tasks, medical robotic devices are designed for entirely different environments and operations relevant to the treatment and prevention of diseases. Therefore, unlike conventional “old” robots, which are built with large mechanical systems, medical robots require miniaturized parts and smart materials for complex and precise operations and mating with the human body. The rapid growth in medical robotics has been driven by a combination of technological advances in motors, control theory, materials, and medical imaging and increase in surgeon/patient acceptance (2–4). For example, robotic surgical systems, such as the da Vinci system, allow translation of the surgeon’s hand movements into smaller, precise movements of tiny instruments within the patient’s body. Despite widespread adoption of robotic systems for minimally invasive surgery, there are still major technical difficulties and challenges (4). In particular, the mechanical parts of existing medical robotic devices are still relatively large and rigid to access and treat major previously inaccessible parts of the human body. Designing miniaturized and versatile robots of a few micrometers or less would allow access throughout the whole human body, leading to new procedures down to the cellular level and offering localized diagnosis and treatment with greater precision and efficiency. Advancing the miniaturization of robotic systems at the micro- and nanoscales thus holds considerable promise for enhancing the treatment of a wide variety of diseases and disorders (5, 6). The development of micro/nanoscale robots for biomedical applications, which is the focus of this Review, has been supported by recent advances in nanotechnology and materials science and has been driven largely by the demands from the biomedical community.
Locomotion represents the first challenge for the miniaturization of robots into micro- and nanoscales. When the dimension of the machine is scaled down, the low Reynolds number environment and Brownian motion pose a major challenge to their locomotion (7, 8). The design of an efficient nano/microscale machine thus requires a swimming strategy that operates under these low Reynolds number constraints and a navigation strategy for overcoming the Brownian motion. Because traditional power supply components and batteries are not possible at these tiny scales, innovative bioinspired design principles are required to meet the challenging powering and locomotion demands. Different types of micro/nanorobots based on distinct actuation principles (Fig. 1A) have been developed in the past decade. Typically, these tiny machines rely on either chemically powered motors that convert locally supplied fuels to force and movement or externally powered motors that mostly use magnetic and ultrasound energies (and sometimes optical, thermal, and electrical energies) to drive their motion (9–20). The fundamental principles of these nanomachines, with rich underlying physics and chemistry, have been discussed in several comprehensive articles (5, 9, 21–23). Chemically powered motors can propel themselves through aqueous solution by using surface reactions to generate local gradients of concentration, electrical potential, and gas bubbles (9, 21, 22). Magnetic swimmers successfully use magnetic actuation to reproduce the motions of natural swimming microorganisms with helical or flexible flagella (5). The proposed propulsion mechanism of acoustic nanomotors suggests that they use asymmetric steady streaming to produce a finite propulsion speed along the axis of the symmetry of the device and perpendicular to the oscillation direction (23). Optical, thermal, and electrical energies can also be harvested to drive the motion of micro/nanostructures with unique principles (24–27). Synthetic micro/nanodevices can also be integrated with motile organisms to build biologically powered hybrid nanorobots (28, 29). These different propulsion principles have led to several micro/nanorobotic prototypes, including fuel-powered tubular microrockets (30), magnetically actuated helical swimmers (31), ultrasound-powered nanowire motors (32), and a sperm-powered biohybrid microrobot (Fig. 1, B to E) (33).
Fig. 1Actuation mechanisms and potential biomedical applications of various types of micro/nanorobots.
(A) Typical propulsion mechanisms of micro/nanoscale robots. (B) Chemically powered microrocket [adapted with permission from (30)]. Scale bar, 50 μm. (C) Magnetically actuated helical nanoswimmer [adapted with permission from (31); copyright 2009 American Chemical Society]. Scale bar, 200 nm. (D) Acoustically propelled nanowire motor [adapted with permission from (32); copyright 2013 American Chemical Society]. Scale bar, 200 nm. (E) Biologically propelled sperm hybrid microrobot [adapted with permission from (33)]. (F) Potential biomedical applications of nanorobots. (G) Magnetic helical microrobot for cargo delivery [adapted with permission from (38)]. Scale bar, 50 μm. (H) Microgrippers for high-precision surgery [adapted with permission from (39)]. Scale bar, 100 μm. (I) Antibody-immobilized microrobot for sensing and isolating cancer cells [adapted with permission from (40)]. Scale bar, 30 μm. (J) RBC membrane–coated nanomotor for biodetoxification [adapted with permission from (41)].
Tremendous efforts from the nanorobotic community have greatly improved the power, motion control, functionality versatility, and capabilities of the various micro/nanorobotic prototypes. The growing sophistication of these nano/microscale robots offers great potential for diverse biomedical applications. Many studies have demonstrated that these micro/nanorobots can navigate through complex biological media or narrow capillaries to perform localized diagnosis, remove biopsy samples, take images, and autonomously release their payloads at predetermined destinations. The energy used to actuate these untethered micro/nanorobots does not require any cables, tethers, or batteries. Many of the micro/nanorobots are made of biocompatible materials that can degrade and even disappear upon the completion of their mission. Significantly, the actuation and biomedical function of several micro/nanorobots in a live animal’s body have been carefully characterized in recent studies (34–37). These preliminary in vivo micro/nanorobot operations have demonstrated their enhanced tissue penetration and payload retention capabilities. Such untethered micro/nanorobots represent an attractive alternative to invasive medical robots and passive drug carriers and are expected to have a major impact on various aspects of medicine. In this review, we summarize potential biomedical applications of micro/nanorobots, as demonstrated in recent proof-of-concept studies, in the following four categories: targeted delivery, precision surgery, sensing of biological targets, and detoxification. Representative examples of such biomedical applications are displayed in Fig. 1 (F to J) (38–41). The immense promise and benefits that these micro/nanorobots bring to the field of biomedicine, along with existing challenges, gaps, and limitations, are discussed in the following sections.
Micro/nanorobots for targeted delivery
Existing drug delivery micro/nanocarriers rely on systemic circulation and lack the force and navigation required for localized delivery and tissue penetration beyond their passive mass transport limitation. To achieve precise delivery of therapeutic payloads to targeted disease sites, drug delivery vehicles are desired to have some unique capabilities, including a propelling force, controlled navigation, cargo-towing and release, and tissue penetration. Although these remain unmet challenges for current drug delivery systems, micro/nanorobots represent a new and attractive class of delivery vehicles that can meet these desirable features. The motor-like micro/nanorobots have the potential to rapidly transport and deliver therapeutic payloads directly to disease sites, thereby improving the therapeutic efficacy and reducing systemic side effects of highly toxic drugs.
Numerous initial studies have been conducted to demonstrate the delivery function and performance of these micro/nanorobots in test tubes and in vitro environments (42–46). For example, Wu et al. (47) reported the preparation of a multilayer tubular polymeric nanomotor encapsulating the anticancer drug doxorubicin via a porous-membrane template-assisted layer-by-layer assembly. The nanomotor was able to deliver the loaded drug to the vicinity of cancer cells. Ma et al. (48) reported a chemically powered Janus nanomotor that functioned as an active nanoscale cargo delivery system and enabled a 100% diffusion enhancement when compared with passive targeting without propulsion. Mou et al. (49) described a biocompatible drug-loaded magnesium-based Janus micromotor that displayed efficient autonomous motion in simulated body fluid or blood plasma (without added fuel) and temperature-triggered release of the drug payload. Gao et al. (50) demonstrated the magnetic micromotor vehicle for directed drug delivery by transporting drug-loaded magnetic polymeric particles to HeLa cells. Walker et al. (51) recently demonstrated that enzymatically active magnetic micropropellers could effectively penetrate mucin gels. Garcia-Gradilla et al. (52) demonstrated that ultrasound-driven nanowire motors could perform rapid drug delivery toward cancer cells followed by a light-triggered release. Most recently, Chen et al. (53) reported a hybrid magnetoelectric nanorobotics design for targeted drug delivery, where drug release can also be triggered by magnetic field.
The pipeline of developing micro/nanorobots for drug delivery is extremely rich, attested by many emerging systems in the early stages of development. Among these, intracellular delivery represents an active and exciting research area, where the nanorobots penetrate through cellular membranes and directly deliver various therapeutic compounds into the cells. For example, the rapid internalization and movement of ultrasound-powered gold nanowire motors within living cells (54) have been further exploited for accelerated intracellular small interfering RNA (siRNA) delivery (55). These siRNA-loaded nanowires were shown to penetrate rapidly into different cell lines and to markedly improve the efficiency and speed of gene silencing process as compared with their static nanowire counterparts. Magnetic helical microswimmers have also been used for targeted delivery of plasmid DNA (pDNA) to human embryonic kidney cells (56). The pDNA-loaded motors were steered wirelessly toward the cells and released their genetic cargo into the cells upon contact.
Although most of these studies have been performed in vitro, initial in vivo studies are already undergoing and have demonstrated encouraging results (34–37, 57). Among the various micro/nanorobotic platforms, synthetic motors that are powered by biological fluids such as gastric acid and water are of particular interest for in vivo applications. In addition to efficient propulsion, these motors have the ability to carry a large amount of different cargos, release payloads in a responsive autonomous manner, and eventually degrade themselves to nontoxic by-products. Recently, Gao et al. (34) conducted the very first in vivo study of chemically powered micromotors. The motors’ distribution, retention, cargo delivery ability, and acute toxicity profile in a mouse’s stomach have been evaluated carefully. With zinc-based micromotors as a model, the acid-driven propulsion in the stomach effectively enhanced the binding and retention of the motors in the stomach wall. The body of the micromotors gradually dissolves in the gastric acid, autonomously releasing their carried payloads, leaving nothing toxic behind (Fig. 2A). Li et al. (35) demonstrated an enteric micromotor capable of precise positioning and controllable retention in desired segments of the gastrointestinal (GI) tract of living mice (Fig. 2B). These motors, consisting of a magnesium-based tubular structure coated with an enteric polymer layer, can act as a robust nanobiotechnology tool for site-specific GI delivery. The in vivo results demonstrate that these motors can safely pass through the gastric fluid and are accurately activated in the GI tract. By simply tuning the thickness of the pH-sensitive polymeric layer, it is possible to selectively activate the propulsion of these motors at desired regions of the GI tract toward localized tissue penetration and retention, without causing noticeable acute toxicity. Most recently, the same team demonstrated that magnesium-based micromotors can autonomously and temporally neutralize gastric acid through efficient chemical propulsion that rapidly depletes localized protons (57). Testing in a mouse model illustrated that such motor-enabled pH change can trigger a responsive payload release. Such pH-neutralizing micromotors can thus combine the functions of proton pump inhibitors and responsive carriers.
Fig. 2Representative examples of micro/nanorobot-based in vivo delivery.
(A) Acid-powered, zinc-based micromotors for enhanced retention in the mouse’s stomach (34). (B) Enteric micromotor, coated with a pH-sensitive polymer barrier (enteric coating) to bypass the acidic stomach environment and to selectively position and spontaneously propel in the GI tract [adapted with permission from (35); copyright 2016 American Chemical Society]. (C) Controlled in vivo swimming of a swarm of bacteria-like microrobotic flagella [adapted with permission from (36)]. (D) Magneto-aerotactic motor-like bacteria delivering drug-containing nanoliposomes to tumor hypoxic regions [reprinted with permission from Macmillan Publishers Ltd. (37); copyright 2016].
In addition to chemically powered motors, fuel-free motors powered by external stimuli, such as magnetic or ultrasound fields, also show promise for some important in vivo applications. Servant et al. (36) reported the in vivo imaging and actuation of a swarm of helical microswimmers under rotating magnetic fields in deep tissue (Fig. 2C). Specifically, the magnetically controlled motion of the microswimmers in the peritoneal cavity of an anesthetized mouse was tracked in real time using fluorescence imaging. These results indicate the possibility of using such magnetic motors for optimal delivery of drugs to a targeted site guided by the external magnetic field. Moreover, Felfoul et al. (37) demonstrated the use of magneto-aerotactic bacteria, Magnetococcus marinus strain MC-1, to transport drug-loaded nanoliposomes into hypoxic regions of tumors (Fig. 2D). In their natural environment, these bacteria tend to swim along local magnetic field lines and toward low oxygen concentrations. When the MC-1 bacteria bearing the drug-containing nanoliposomes were injected into tumor-bearing mice and magnetically guided toward the tumor, up to 55% of the MC-1 bacteria penetrated into the hypoxic regions of HCT116 colorectal xenograft tumor. Superior penetration depths in xenograft tumors were observed compared with the passive agents. These results suggest that harnessing swarms of microorganisms exhibiting magneto-aerotactic behavior can significantly improve the delivery efficiency of drug nanocarriers to tumor hypoxic regions. Considering the tremendous progress made recently in the development of micro/nanorobots and their uses toward in vivo delivery, these micro/nanorobots are expected to become powerful active transport vehicles that may enable a variety of therapeutic applications that are otherwise difficult to achieve through the exiting passive delivery systems.
Micro/nanorobots for precision surgery
Robotic systems have been introduced for reducing the difficulties associated with complex surgical procedures and for extending the capabilities of human surgeons. Such robot-assisted surgery is a rapidly evolving field that allows doctors to perform a variety of minimally invasive procedures with high precision, flexibility, and control (58, 59). Unlike their large robotic counterparts, tiny robots can potentially navigate throughout human body, operate in many hard-to-reach tissue locations, and hence target many specific health problems.
Recent advances in micro/nanorobots have shown considerable promise for addressing these limitations and for using these tiny devices for precision surgery (3, 60). Untethered micro/nanorobotic tools, ranging from nanodrillers to microgrippers and microbullets (Fig. 3), offer unique capabilities for minimally invasive surgery. With dimensions compatible with those of the small biological entities that they need to treat, micro/nanorobots offer major advantages for high-precision, minimally invasive surgery. Powered by diverse energy sources, the moving micro/nanorobots with nanoscale surgical components are able to directly penetrate or retrieve cellular tissues for precision surgery. Unlike their large robotic counterparts, these tiny robots can navigate through the body’s narrowest capillaries and perform procedures down to the cellular level.
Fig. 3Representative examples of micro/nanorobot-enabled precision surgery.
(A) Tetherless thermobiochemically actuated microgrippers capturing live fibroblast cells [adapted with permission from (39)]. (B) Electroforming of implantable tubular magnetic microrobots for wireless eye surgery [adapted with permission from (64)]. (C) Acoustic droplet vaporization and propulsion of perfluorocarbon-loaded microbullets for tissue ablation [adapted with permission from (65)]. (D) Self-propelled nanodriller operating on a single cell [adapted with permission from (67); copyright 2012 American Chemical Society]. (E) Medibots: dual-action biogenic microdaggers for single-cell surgery [adapted with permission from (69)].
Tetherless microgrippers represent an important step toward the construction of autonomous robotic tools for microsurgery (17, 61). These mobile microgrippers can capture and retrieve tissues and cells from hard-to-reach places. Conventional microgrippers are usually tethered and actuated by mechanical or electrical signals, generated from control systems, via external connections (e.g., wires and tubes) that restrict their miniaturization and maneuverability. Similar to their large tethered counterparts, the gripping operation of untethered microgrippers commonly involves an opening/closing of the device. Leong et al. (39) have developed a set of responsive microgrippers that can be actuated autonomously by diverse environmental factors and used as minimally invasive microsurgical tools. These microgrippers can be mass-produced using conventional multilayer photolithography with shapes modeled after biological appendages, in which the jointed digits are arranged in different ways around a central palm (62). By relying on a built-in self-folding actuation response (triggered by their surrounding biological environment), such soft microgrippers obviate the need for external tethers. Different responsive mechanisms, based on temperature, pH, or enzyme stimuli, have been explored for actuating self-folding microgrippers autonomously in specific environments (63). For example, Fig. 3A illustrates the ability of a tetherless thermobiochemically actuated microgripper to capture a cluster of live fibroblast cells from a dense cell mass in a capillary tube. The microgripper could subsequently move out of the capillary tube with the captured cells in its grasp, demonstrating its strength for performing an in vitro tissue biopsy. The ability to perform additional biomedical functions, such as ablation, has been demonstrated (17).
Magnetically actuated microrobots have also shown considerable promise for minimally invasive in vivo surgical operations because magnetic fields are capable of penetrating thick biological tissues. Chatzipirpiridis et al. (64) demonstrated that an implantable magnetic tubular microrobot was able to perform such surgery at the posterior segment of the eye (Fig. 3B). The electrochemically prepared microrobot was injected with a 23-gauge needle into the central vitreous humor of the eye and monitored with an ophthalmoscope and integrated camera. Wireless control was used to rotate the intraocular magnetic microrobot around three axes in the vitreous humor of a living rabbit eye. Similar magnetic microtubes can be developed and applied as implantable devices for targeting other diseases in different confined spaces of the human body.
Ultrasound actuation has recently been used to create powerful microrobots with remarkable tissue penetration properties. Kagan et al. (65) demonstrated an ultrasound-triggered, high-velocity, “bullet-like” propulsion, enabled by the fast vaporization of biocompatible fuel (i.e., perfluorocarbon). Such conically shaped tubular microbullets, containing the fuel source, display an ultrafast movement with speeds of over 6 m/s (corresponding to 160,000 body lengths per second) in response to an external ultrasound stimulus. Such remarkable speed can provide sufficient thrusts for deep tissue penetration, ablation, and destruction (Fig. 3C). Similar acoustically triggered vaporization of perfluorocarbon fuel was also used for developing tubular microscale cannons capable of loading and firing nanobullets at remarkable speeds (66). These microballistic tools could be used to eject high-speed nanobullets and shoot a wide range of payloads deep into diseased tissues. Recent proof-of-concept studies have demonstrated that the untethered micro/nanorobots can perform surgical operation on a single-cell level. Solovev et al. (67) described nanoscale tools in the form of autonomous and remotely guided catalytic InGaAs/GaAs/(Cr)Pt microjets. With diameters of 280 to 600 nm, these self-propelled rolled-up tubes can reach a speed of up to 180 μm/s in hydrogen peroxide solutions. The effective transfer of chemical energy to a translational corkscrew-like motion has allowed these tubes to drill and embed themselves into biological samples such as a single cell (Fig. 3D). Although hydrogen peroxide may be incompatible for live-cell applications, the same team also described fuel-free rolled-up magnetic microdrillers that could be remotely controlled by a rotational magnetic field (68). The self-folded magnetic microtools with sharp ends enabled drilling and related incision operations of pig liver tissues ex vivo. Srivastava et al. (69) also demonstrated that magnetically powered microdaggers could create a cellular incision followed by drug release to facilitate highly localized drug administration (Fig. 3E). These studies have demonstrated the great potential of micro/nanorobots for performing precision surgery at the cellular or even subcellular level. The potential of surgical nanorobots will be greatly improved by their ability to penetrate and resect tissues and to sense specific targets, through the choice of propulsion method and the use of real-time localization and mapping with a robust control system.
Micro/nanorobots for sensing
Owing to their unique features of autonomous motion, easy surface functionalization, as well as effective capture and isolation of target analytes in complex biological media, micro/nanorobots have shown considerable promise for performing various demanding biosensing applications toward precise diagnosis of diseases. The micro/nanorobot sensing strategy relies on the motility of artificial nanomotors, functionalized with different bioreceptors (Fig. 4A), through the sample to realize “on-the-fly” specific biomolecular interactions (12, 16). Such receptor-functionalized micro/nanomotors offer powerful binding and transport capabilities that have led to new routes for detecting and isolating biological targets, such as proteins, nucleic acids, and cancer cells, in unprocessed body fluids (32, 70–72). The continuous movement of these functionalized synthetic motors leads to built-in solution mixing in microliter clinical samples, which greatly enhances the target binding efficiency and offers major improvements in the sensitivity and speed of biological assays (73). Furthermore, the efficient cargo-towing ability of such self-propelled nanomotors, along with their precise motion control within microchannel networks, can lead to new medical diagnostic microchips powered by active transport (74).
Fig. 4Strategies and examples of micro/nanorobots for sensing.
(A) Functionalization of micro/nanorobot with different bioreceptors toward biosensing of target analytes, including cells, proteins, and nucleic acids. (B) ssDNA-functionalized microrockets for selective hybridization and isolation of nucleic acids [adapted with permission from (75); copyright 2011 American Chemical Society]. (C) Specific intracellular detection of miRNA in intact cancer cells using ultrasound (US)–propelled nanomotors [adapted with permission from (80); copyright 2015 American Chemical Society].
Several examples of such bioreceptor-functionalized micro/nanomotors for the detection and isolation of different types of bioanalytes are displayed in Fig. 4 (B and C). Figure 4Bdemonstrates efficient on-the-fly DNA hybridization in complex media by using oligonucleotide probe–functionalized micromotors, which allows sensitive and selective detection of nanomolar levels of target DNA sequences (75). A similar strategy using aptamer-functionalized tubular microengines demonstrated the sensitive and selective isolation of thrombin from biological samples (76). Tubular microrockets functionalized with targeting ligands, such as antibodies, offer on-the-fly recognition and isolation of specific cancer cells (40). These micromotors provide sufficient propulsive force for efficient transport of the captured target cells in untreated biological media. The micromotor-based target isolation approach can be readily incorporated into lab-on-a-chip diagnostic devices, thus integrating autonomous capture, active transport, release, and detection operations within their different reservoirs and narrow microchannels (74, 77, 78). The significant mixing—induced by the motion of unmodified self-propelled motors—has been shown to greatly enhance analyte-bioreceptor interactions and hence the sensitivity of an immunoassay microarray, as was demonstrated for detecting an Alzheimer biomarker target (79).
Beyond detection and transportation of biological individuals in ambient environments outside of cells, the internalization and movement of nanorobots within cells can also be exploited for intracellular sensing. For example, Esteban-Fernández de Ávila et al. (80) introduced an attractive intracellular “off-on” fluorescence strategy for detecting the endogenous content of target microRNA-21 (miRNA-21) based on the use of an ultrasound-propelled nanomotor functionalized with single-stranded DNA (ssDNA) (Fig. 4C). The presence of the target miRNA resulted in displacement of the dye-ssDNA probe from the surface and a fast fluorescence recovery of the quenched dye-labeled specific ssDNA probe. Such nanomotor biosensing approach could find important applications for profiling miRNA expression at the single-cell level in a variety of clinical scenarios.
Micro/nanorobots for detoxification
Self-propelled micro/nanorobots have also been used as powerful detoxification tools with high cleaning capability. Similar to biosensing, detoxification strategies rely on self-propelled micro/nanorobots that rapidly capture and remove the toxin to render the environment nontoxic. Efficient motion would facilitate the collision and binding of toxins to the motors, which are coated with desired functional materials. For example, nanomotors have been combined with cell-derived natural materials—capable of mimicking the natural properties of their source cells—toward novel nanoscale biodetoxification devices. Among different cell derivatives, red blood cells (RBCs) have shown excellent capability to function as toxin-absorbing nanosponges to neutralize and remove dangerous “pore-forming toxins” (PFTs) from the bloodstream (Fig. 5A) (81). Motivated by the biological properties of RBCs, several different types of cell-mimicking micromotors have been developed for detoxification. Wu et al. (82) presented a cell-mimicking, water-powered micromotor based on RBC membrane–coated magnesium microparticles, which were able to effectively absorb and neutralize α-toxin in biological fluids (Fig. 5B). Another detoxification strategy explored the combination of RBC membranes with ultrasound-propelled nanomotors as a biomimetic platform to effectively absorb and neutralize PFTs (41). Another microrobot-based detoxification approach was based on the use of a self-propelled three-dimensional (3D)–printed microfish containing polydiacetylene nanoparticles (Fig. 5C, top), which served to attract, capture, and neutralize toxins via binding interactions (83). Self-propelled 3D microfishes incubated in the toxin solution showed higher fluorescence intensities (Fig. 5C, bottom) compared with static microfishes, highlighting the importance of active motion for enhancing the detoxification processes.
Fig. 5Representative examples of micro/nanorobots for detoxification.
(A) Transmission electron microscope image of a cell membrane–coated nanosponge used for toxin neutralization [reprinted with permission from Macmillan Publishers Ltd. (81); copyright 2013]. (B) Scheme of the RBC-Mg Janus micromotor moving in biological fluid (left) and their capacity for cleaning of α-toxin [adapted with permission from (82)]. (C) Scanning electron microscope image of a 3D-printed microfish (top) and fluorescence image of the microfish incubated in melittin toxin solution after swimming (bottom) [adapted with permission from (83)].
Conclusions, gaps, and outlook
Over the past decade, micro/nanorobotics has emerged as a novel and versatile platform to integrate the advantages of nanotechnologies and robotic sciences. A diverse set of design principles and propulsion mechanisms have thus led to the development of highly capable and specialized micro/nanorobots. These micro/nanorobots have unique and multivalent functionalities, including fast motion in complex biological media, large cargo-towing force for directional and long-distance transport, easy surface functionalization for precise capture and isolation of target individuals, and excellent biocompatibility for in vivo operation. These attractive functionalities and capabilities of micro/nanorobots have facilitated biomedical applications, ranging from targeted delivery of payloads and precise surgery on a cellular level to ultrasensitive detection of biological molecules and rapid removal of toxic compounds. These developments have advanced the micro/nanorobots from chemistry laboratories and test tubes to whole living systems. Such in vivo studies serve as an important step forward toward clinical translation of the micro/nanorobots.
The ability of micro/nanorobots to address health care issues is just in its infancy. Overcoming knowledge gaps in nanorobotics could have a profound impact on different medical domains. Tremendous efforts and innovations are required for realizing the full potential of these tiny robots for performing complex operations within body locations that were previously inaccessible. Future micro/nanorobots must mimic the natural intelligence of their biological counterparts (e.g., microorganisms and molecular machines) with high mobility, deformable structure, adaptable and sustainable operation, precise control, group behavior with swarm intelligence, sophisticated functions, and even self-evolving and self-replicating capabilities.
A significant challenge is to identify new energy sources for prolonged, biocompatible, and autonomous in vivo operation. Although different chemical fuels and external stimuli have been explored for nanoscale locomotion in aqueous media (8), new alternative fuels and propulsion mechanisms are necessary for safe and sustainable operation in the human body. Most of the catalytic micromotors rely on hydrogen peroxide fuel and hence can only be used in vitro. Micromotors powered by active material propellants (e.g., Mg, Zn, Al, and CaCO3) have relatively short lifetimes because of rapid consumption of their propellant during their propulsion. Recent efforts have indicated that enzyme-functionalized nanomotors could be powered by bodily fluid constituents, such as blood glucose or urea (84–86). The power and stability of these enzyme-based motors require further improvements for practical implementation. Magnetic and acoustic nanomotors can provide fuel-free and on-demand speed regulation, which is highly suitable for nanoscale surgery but may hinder autonomous therapeutic interventions.
Moving nanorobots from test tubes to living organisms would require significant future efforts. The powerful performance of micro/nanorobots has already been demonstrated in viscous biological fluids such as gastric fluid or whole blood (34, 35, 57, 87, 88). Operating these tiny devices in human tissues and organs that impose larger barriers to motion requires careful examination. Magnetically powered microswimmers have been successfully actuated in the peritoneal cavity of a mouse using a weak rotating magnetic field of 9 mT (36). Magneto-aerotactic bacteria were able to migrate into tumor hypoxic regions under a focalized directional magnetic field of only 15 G (37). Ultrasound-powered micromotors with powerful “ballistic” capabilities have enabled deep tissue penetration (65). Powering nanorobot within tissues and organs could greatly benefit from their small size. Such “small is better” philosophy has already been verified using nanoscale magnetic propellers, which display a significant advantage for propulsion in viscoelastic hyaluronan gels because they are of the same size range as the openings in the gel’s mesh, compared with the impeded motion of larger propellers (89). These results demonstrate that nanorobots are highly promising for achieving efficient motion in tissues enabled by the nanoscale size and optimized design. The miniaturization advantages of smaller nanorobots have also been realized for overcoming cellular barriers and internalizing into cells (55).
Designing robots to perform tasks at the nanoscale is essentially a materials science or surface science problem because the operation and intelligence of tiny robots rely primarily on their materials and surface properties. Biomedical nanorobots are designed for environments involving unanticipated biological events, changing physiological conditions, and soft tissues. Therefore, diverse smart materials, such as biological materials, responsive materials, or soft materials, are highly desired to provide the necessary actuation and multifunctionality while avoiding irreversible robotic malfunctions in complex physiologically relevant body systems. Recent report has shown that the macrophage uptake of rotating magnetic microrobots could be avoided by adjusting the rotational trap stiffness (90). Alternatively, coupling synthetic nanomachines with natural biological materials can minimize undesired immune evasion and biofouling effects experienced in complex biological fluids, leading to enhanced mobility and lifetime in these media (82). Responsive materials are highly desired for designing configurable nanorobots for adaptive operation under rapidly changing conditions. Nanorobots are also desired to be soft and deformable to ensure maneuverability and mechanical compliance to human body and tissues (91, 92). Eventually, they should be made of transient biodegradable materials that disappear upon completing their tasks (93). New fabrication and synthesis approaches, such as 3D nanoprinting, should be explored for large-scale, high-quality, and cost-efficient fabrication of biomedical nanorobots. Advancing nanorobots into the next level will thus be accomplished with new smart materials and cutting-edge fabrication techniques.
Biomedical nanorobots are expected to cooperate, with thousands of units moving independently and coordinately to target the disease site. The coordinated action of multiple nanorobots could be used for performing tasks (e.g., effective delivery of large therapeutic payloads or large-scale detoxification processes) that are not possible using a single robot. Although individual navigation and collective behavior of nanorobots have been explored, mimicking the natural intelligence group communication and synchronized coordination, from one to many, is a challenging issue. Advancing the swarm intelligence of nanorobots toward group motion planning and machine learning at the nanoscale is highly important for enhancing their precision treatment capability. Fundamental understanding of “active matter” and related quantitative control theory can guide the realization of such swarming behavior in dynamically changing environments. High-resolution simultaneous localization and mapping of nanorobots in the human body are experimentally difficult using conventional optical microscopy techniques. Future biomedical operation of nanorobots will require their coupling with modern imaging systems and feedback control systems for arbitrary 4D navigation of many-nanorobot systems.
Looking to the future, the development and application of micro/nanorobots in medicine is expected to become a vigorous research area. To realize the full potential of the micro/nanorobots in the medical field, nanorobotic scientists should work more closely with medical researchers for thorough investigations of the behavior and functionality of the robots, including studies on their biocompatibility, retention, toxicity, biodistribution, and therapeutic efficacy. Considering the promising results achieved recently in GI delivery and ophthalmic therapies, we strongly encourage nanorobotic scientists to look into the demands and needs of the medical community to design problem-oriented medical device for specific diagnostic or therapeutic functions. Addressing these specific needs will lead to accelerated translation of micro/nanorobots research into practical clinical use. We envision that with close collaboration between the nanorobotic and medical communities, these challenges can be gradually addressed, eventually expanding the horizon of micro/nanorobots in medicine.
REFERENCES AND NOTES
Funding: This work is supported by the Defense Threat Reduction Agency Joint Science and Technology Office for Chemical and Biological Defense (grant numbers HDTRA1-13-1-0002 and HDTRA1-14-1-0064) and by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH (award number R01DK095168).
- Copyright © 2017, American Association for the Advancement of Science
Комментариев нет:
Отправить комментарий